New York Gov. Hochul declares state disaster emergency over monkeypox

New York Gov. Hochul declares state disaster emergency over monkeypox


People wait on line to register for a monkeypox vaccination shot on July 29, 2022 in New York City.

John Smith | Corbis News | Getty Images

New York Gov. Kathy Hochul declared a state disaster emergency Friday night over the continued spread of monkeypox.

She said the emergency declaration would lead to swifter response and better vaccination distribution. It came a day after the state declared monkeypox an imminent threat to public health in New York.

“I am declaring a State Disaster Emergency to strengthen our ongoing efforts to confront the monkeypox outbreak,” Hochul tweeted Friday.

Hochul indicated New York is an emerging center for the virus, which manifests in symptoms of rashes and lesions across the body, extremities and genitals.

“More than one in four monkeypox cases in this country are in New York,” she wrote, “currently having a disproportionate impact on at-risk groups.”

The virus, spread through physical contact, can develop flu-like symptoms, and its initial impacts can last as long as four weeks.

“We are working around the clock to secure more vaccines, expand testing capacity, and educate New Yorkers on how to stay safe,” Hochul said.



Source

Healthy Returns: New study casts doubts on RFK Jr.’s reasons for gutting key vaccine panel
Health

Healthy Returns: New study casts doubts on RFK Jr.’s reasons for gutting key vaccine panel

U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. speaks as he attends a press conference with Centers for Medicare and Medicaid Services Administrator Mehmet Oz to discuss health insurance reform, at the Department of Health and Human Services in Washington, D.C., U.S., June 23, 2025. Kevin Mohatt | Reuters A version of […]

Read More
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Health

Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data

Shares of Viking Therapeutics fell more than 30% in premarket trading Tuesday after the company released mid-stage trial data on its obesity pill that disappointed investors.  The results could be a blow to Viking, which was once seen as a hot M&A target as pharmaceutical companies scramble to join the booming market for obesity and […]

Read More
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Health

Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients

A box of Ozempic made by Novo Nordisk, at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it now offers cash-paying U.S. patients its blockbuster diabetes treatment Ozempic for less than half its monthly list price, as drugmakers face mounting political pressure to lower prices in […]

Read More